These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37972710)

  • 1. Use of 2% taurolidine lock solution for treatment and prevention of catheter-related bloodstream infections in neonates: a feasibility study.
    Savarese I; Yazami S; De Rose DU; Carkeek K; Campi F; Auriti C; Danhaive O; Piersigilli F
    J Hosp Infect; 2024 Jan; 143():76-81. PubMed ID: 37972710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
    Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
    Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
    [No Abstract]   [Full Text] [Related]  

  • 4. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
    Gudiol C; Arnan M; Aguilar-Guisado M; Royo-Cebrecos C; Sánchez-Ortega I; Montero I; Martín-Gandul C; Laporte-Amargós J; Albasanz-Puig A; Nicolae S; Perayre M; Berbel D; Tebe C; Riera J; Sureda A; Cisneros JM; Carratalà J
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurolidine and Heparin as Catheter Lock Solution for Central Venous Catheters in Hemodialysis.
    Nguyen T; Camins BC; Butler DA
    Am J Ther; 2024 Jul-Aug 01; 31(4):e398-e409. PubMed ID: 38710029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
    Neusser MA; Bobe I; Hammermeister A; Wittmann U
    Br J Nurs; 2021 Jul; 30(14):S24-S32. PubMed ID: 34288746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
    Klek S; Szczepanek K; Hermanowicz A; Galas A
    JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
    Chong CY; Ong RY; Seah VX; Tan NW; Chan MY; Soh SY; Ong C; Lim AS; Thoon KC
    J Paediatr Child Health; 2020 Jan; 56(1):123-129. PubMed ID: 31145505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis.
    Sun Y; Wan G; Liang L
    PLoS One; 2020; 15(4):e0231110. PubMed ID: 32255798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.
    Demirok A; Illy DHC; Nagelkerke SQ; Lagerweij MF; Benninga MA; Tabbers MM
    JPEN J Parenter Enteral Nutr; 2024 May; 48(4):486-494. PubMed ID: 38605559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of long-term catheter-related bloodstream infections with short-course Daptomycin lock and systemic therapy associated with Taurolidine-lock: A multicenter experience.
    Vassallo M; Denis E; Manni S; Lotte L; Fauque P; Sindt A
    J Vasc Access; 2024 Jul; 25(4):1146-1150. PubMed ID: 36726226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
    Al-Amin AH; Sarveswaran J; Wood JM; Burke DA; Donnellan CF
    J Vasc Access; 2013; 14(4):379-82. PubMed ID: 23817948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
    Chu HP; Brind J; Tomar R; Hill S
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Taurolidine for the prevention of catheter-related infections in children with intestinal insufficiency: preliminary experience in a Chilean tertiary hospital].
    Jordán P M; Haro C; Puchi A
    Rev Chilena Infectol; 2021 Feb; 38(1):15-21. PubMed ID: 33844787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Taurolidine, an antiseptic for the prevention of central venous catheter-related infections].
    Haro C
    Rev Chilena Infectol; 2019 Aug; 36(4):414-420. PubMed ID: 31859763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
    Handrup MM; Møller JK; Schrøder H
    Pediatr Blood Cancer; 2013 Aug; 60(8):1292-8. PubMed ID: 23417891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.
    Agarwal AK; Roy-Chaudhury P; Mounts P; Hurlburt E; Pfaffle A; Poggio EC
    Clin J Am Soc Nephrol; 2023 Nov; 18(11):1446-1455. PubMed ID: 37678222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
    Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients.
    Brescia F; Pittiruti M; Scoppettuolo G; Zanier C; Nadalini E; Bottos P; Moreal C; Da Ros V; Fabiani F
    J Vasc Access; 2023 Jan; 24(1):87-91. PubMed ID: 34148394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition.
    Vernon-Roberts A; Lopez RN; Frampton CM; Day AS
    JPEN J Parenter Enteral Nutr; 2022 Sep; 46(7):1535-1552. PubMed ID: 35233792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.